Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(14%)
Results Posted
100%(3 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_3
3
43%
Ph phase_2
3
43%

Phase Distribution

0

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
unknown1
Terminated1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (50.0%)
Phase 33 (50.0%)

Trials by Status

completed343%
unknown114%
terminated114%
active_not_recruiting114%
not_yet_recruiting114%

Recent Activity

1 active trials
Showing 5 of 7
not_yet_recruitingphase_3

Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)

NCT07681713
completedphase_2

A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

NCT04577352
unknown

Vatiquinone Expanded Access Protocol

NCT07159139
terminatedphase_2

A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

NCT04378075
completedphase_3

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

NCT05218655
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07681713Phase 3

Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)

Not Yet Recruiting
NCT04577352Phase 2

A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

Completed
NCT07159139

Vatiquinone Expanded Access Protocol

Unknown
NCT04378075Phase 2

A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Terminated
NCT05218655Phase 3

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

Completed
NCT05515536Phase 3

A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia

Active Not Recruiting
NCT05485987Phase 2

A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7